On the recordJuly 19, 2011
Do you believe that the clinical trial standards laid out by FDA in the premarket approval process are rigorous enough to prove safety and effectiveness of class III devices?
Source
congress.govJohn Dingell: “Do you believe that the clinical trial standards laid out by FDA in the premarket approval process are rigorous enough…”
Editor's note · Context
Dingell questions the adequacy of FDA's clinical trial standards for class III devices.
Share
More from John Dingell
Jul 22, 2014
It is a very happy system. It works well. And it has had no controversy that I can recall except one instance.
Jul 22, 2014
This year is the 80th Anniversary of the issuance of the first Federal Duck Stamp.
Other voices in this conversation
